Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 18, 1988 - Issue 2
7
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Oxidation of nilvadipine, a new dihydropyridine calcium antagonist, to the corresponding pyridine by rat liver microsomes

, &
Pages 217-224 | Received 19 Mar 1987, Published online: 30 Sep 2009
 

Abstract

1. The oxidation of nilvadipine, a 1,4-dihydropyridine derivative, by rat liver microsomes and sex-related differences in this activity were investigated.

2. The kinetic data (Km and Vmax) for the formation of the corresponding pyridine analogue by liver microsomes from adult male rat (7 weeks old) were similar to those for the disappearance of nilvadipine, indicating that the aromatization of nilvadipine is the primary metabolic step.

3. The formation of the pyridine analogue required the presence of NADPH-generating system and was significantly inhibited by cytochrome c, metyrapone, and 7,8-benzoflavone, indicating the participation of cytochrome P-450. Phenobarbital pretreatment of rats caused an increase in the metabolism of nilvadipine.

4. Nilvadipine oxidase activity in adult male rat was about 10 times higher than that in adult female rat. In contrast, marked sex-related differences were not seen in immature rat (21 days old), and the activity was approximately twice as high as that in adult female rat. No activity was detected in the postmitochondrial fractions of lung, kidney, brain, heart, pancreas or small intestine of adult male rat.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.